Voci, D., Götschi, A., Held, U., Bingisser, R., Colucci, G., Duerschmied, D., Fumagalli, R. M., Gerber, B., Hasse, B., Keller, D. I., Konstantinides, S. V., Mach, F., Rampini, S. K., Righini, M., Robert-Ebadi, H., Rosemann, T., Roth-Zetzsche, S., Sebastian, T., Simon, N. R., Spirk, D., Stortecky, S., Vaisnora, L., Kucher, N., Barco, S., & , (2023). enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial. Thrombosis research, (221), 157–163. http://access.bl.uk/ark:/81055/vdc_100173088982.0x000053